journal
https://read.qxmd.com/read/37550823/a-rare-case-of-nontuberculous-mycobacterial-abscess-mimicking-brain-tumor-in-an-immunocompetent-patient
#21
Junho Jung, Ilyoung Shin, Younghee Choi
Nontuberculous mycobacteria (NTM) is a type of bacteria that typically infects the pulmonary system, and NTM-central nervous system (CNS) infection, which occurs in the brain, is a very rare disease. A 64-year-old female patient presented with seizures as the main symptom and was found to have a mass of less than 1 cm in the right temporal lobe with accompanying edema. Although diseases such as tumor metastasis and parasitic cyst were suspected, the patient underwent a surgical resection, and NTM-CNS infection with abscess was diagnosed through biopsy...
July 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37550822/delayed-detection-of-a-5-aminolevulinic-acid-in-vivo-a-case-of-metastatic-breast-cancer
#22
Hyung Min Kim, Min Ho Lee, Tae-Kyu Lee
A 44-year-old female patient who had been diagnosed with breast cancer visited our oncology department. She had developed right-side weakness and mild dysarthria, and MRI revealed a 4-cm cystic-enhancing lesion in her left frontal lobe. Her surgery was postponed 48 hours after receiving 5-aminolevulinic acid (5-ALA), because a problem with thyroid function that had not been noticed before was discovered. The main lesion was enhanced on navigation and appeared to be a gross tumor; its 5-ALA uptake was very high...
July 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37550821/radiologic-follow-up-of-ruptured-arachnoid-cysts-with-or-without-hemorrhage-five-case-reports-and-a-review-of-the-literature
#23
Ga-Eun Kim, Su-Jee Park, Yeong Jin Kim, Seul-Kee Kim, Tae-Young Jung
Arachnoid cysts are usually asymptomatic and discovered incidentally. However, cysts may occasionally rupture because of minor head trauma. We describe the radiologic follow-up of 5 patients with ruptured arachnoid cysts featuring spontaneous resolution, subdural hygroma formation, and cystic and subdural hemorrhage. From January 2004 through July 2020, 5 patients (1.3%) with ruptured arachnoid cysts were evaluated out of 388 patients with arachnoid cysts encountered at our institution at that time. The 5 patients were all male, and they ranged in age from 6-17 years (median, 12 years)...
July 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37550820/role-of-immediate-postoperative-prolactin-measurement-in-female-prolactinoma-patients-predicting-long-term-remission-after-complete-tumor-removal
#24
JOURNAL ARTICLE
Gi Yeop Lee, Sun Ho Kim, Eui Hyun Kim
BACKGROUND: Transsphenoidal surgery is one of the important treatment options in the management of prolactinomas; however, complete resection of the tumor does not always lead to endocrinological remission. While many studies have investigated preoperative factors associated with surgical outcome, little has been known about the relationship between postoperative factors and long-term surgical outcomes; moreover, there is no consistency in results. The aim of this study was to demonstrate the reliability of immediate postoperative prolactin levels as predictors of long-term outcomes...
July 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37550819/comparing-the-expression-of-canonical-and-non-canonical-inflammasomes-across-glioma-grades-evaluating-their-potential-as-an-aggressiveness-marker
#25
JOURNAL ARTICLE
Yu Jin Kim, Wooseok Choi, JeongMin Sim, Ju Won Ahn, JeongMan Park, Dongkil Kim, Ju-Yeon Jeong, Ji Min Lee, Kyunggi Cho, Jong-Seok Moon, Ju Hyung Moon, Kyoung Su Sung, Jaejoon Lim
BACKGROUND: Inflammasomes are key in the initiation of inflammatory responses and serve to defend the organism. However, when the immune system is imbalanced, these complexes contribute to tumor progression. The purpose of this study was to investigate the effect of non-canonical inflammasomes on glioma malignancy. METHODS: We performed bioinformatics analysis to confirm the expression of canonical and non-canonical inflammasome-related molecules according to the degree of malignancy through immunohistochemical examination of glioma tissues obtained with patient consent from our institution...
July 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37550818/factors-associated-with-neurocognitive-impairment-following-chemoradiotherapy-in-patients-with-high-grade-glioma-results-of-a-prospective-trial
#26
JOURNAL ARTICLE
Prashasti Sharma, Partha Pratim Medhi, Apurba Kumar Kalita, Mouchumee Bhattacharyya, Jyotiman Nath, Gautam Sarma, Yanpothung Yanthan
BACKGROUND: High-grade gliomas (HGG) are highly fatal tumors despite advanced multimodality management. They are also associated with neurocognitive impairment, both due to disease pathology and treatment. We aimed to assess various risk factors responsible for neurocognitive decline in HGG patients undergoing adjuvant chemoradiation. METHODS: Newly diagnosed HGG patients who underwent maximal safe resection were included. Patients received volumetric modulated arc therapy to a dose of 60 Gy in 30 fractions, along with concurrent temozolomide (TMZ) at a dose of 75 mg/m²/day orally; thereafter adjuvant TMZ (150-200 mg/m² for 5 days), given every 28 days for 6 to 8 cycles...
July 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37550817/yesterdays-todays-and-tomorrows-korean-society-for-pediatric-neuro-oncology
#27
REVIEW
Se Hoon Kim
In 2022, in celebration of the 20th anniversary of the Korean Society for Pediatric Neuron-Oncology (KSPNO), a commemorative meeting was held with former and current members. At the meeting, there was a special lecture for the retrospect of the Emeritus Professor Thad Ghim, one of the founders and the 1st president (2002-2003) of KSPNO. He celebrated the history and development of the KSPNO, along with the vision of our society. Especially he appreciated the efforts and endeavors of our senior members. In 2001, we started as "Korean Pediatric Neuro-Oncological Study Group...
July 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37550816/pituitary-neuroendocrine-tumor-is-it-benign-or-malignant
#28
REVIEW
Chae Heuck Lee
The World Health Organization (WHO) updated the classification of pituitary tumors in 2022. The new classification presents detailed histological subtyping of a pituitary neuroendocrine tumor (PitNET) based on the tumor cell lineage, cell type, and related characteristics. The immunohistochemistry for pituitary transcription factors (PIT1, TPIT, SF1, GATA3, and ERα) is routinely needed in this classification. The controversy regarding the change of behavior code of all PitNET/pituitary adenoma from "0" for benign tumors to "3" for primary malignant tumors is a topic of debate among experts, nowadays...
July 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37550815/supramaximal-resection-for-glioblastoma-redefining-the-extent-of-resection-criteria-and-its-impact-on-survival
#29
REVIEW
Tae Hoon Roh, Se-Hyuk Kim
Glioblastomas (GBMs) are the most common and aggressive primary brain tumors, and despite advances in treatment, prognosis remains poor. The extent of resection has been widely recognized as a key factor affecting survival outcomes in GBM patients. The surgical principle of "maximal safe resection" has been widely applied to balance tumor removal and neurological function preservation. Historically, T1-contrast enhanced (T1CE) extent of resection has been the focus of research; however, the "supramaximal resection" concept has emerged, advocating for even greater tumor resection while maintaining neurological function...
July 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37550814/medical-applications-of-3d-printing-and-standardization-issues
#30
REVIEW
Kyu Won Shim
The three-dimensional (3D) printing itself is not a novel technology, it is more than 30 years old. Stereolithographic (SLA) technology has been used as the first and popular technology for medical application of 3D printing. Since 1991 Radiology and Plastic Surgery have published articles about SLA for rapid prototyping anatomical 3D models. Medical applications of 3D printing have been popularizing and stabilizing so far. Implantable medical devices such as metal or absorbable implants, surgical guide systems, prosthesis and orthosis, and 3D anatomical models for normal or diseased anatomy have been developing and expanding its markets so far...
July 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37151158/pituitary-apoplexy-after-leuprolide-therapy-in-a-breast-cancer-patient-a-case-report
#31
Jungbin Lee, Sun-Chul Hwang, Sung-Tae Park
Pituitary apoplexy (PA) is a clinical syndrome resulting from sudden hemorrhage and/or infarction of the pituitary gland. Recent reports documented the development of PA secondary to treatment with gonadotropin-releasing hormone (GnRH) agonists for prostate cancer. A 52-year-old woman visited our emergency room with a severe headache, occurred 1 day prior. She underwent breast-conserving surgery for breast cancer 1 month prior. She was currently undergoing radiation and hormone therapy, consisting of leuprorelin...
April 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37151157/awake-craniotomy-and-intraoperative-musical-performance-for-brain-tumor-surgery-case-report-and-literature-review
#32
Charles E Mackel, Eduardo E Orrego-Gonzalez, Rafael A Vega
Music experience and creation is a complex phenomenon that involves multiple brain structures. Music mapping during awake brain surgery, in addition to standard speech and motor mapping, remains a controversial topic. Music function can be impaired selectively, despite overlap with other neural networks commonly tested during direct cortical stimulation. We describe the case of a 34-year-old male patient presenting with a glioma located within eloquent cortex, who is also a professional musician and actor. We performed an awake craniotomy (AC) that mapped the standard motor and speech areas, while the patient played guitar intraoperatively and sang...
April 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37151156/a-meningioma-with-extensive-peritumoral-edema-mimicking-metastatic-brain-tumor-a-case-report
#33
Princi D Demaisip, Dan Neftalie Juangco, Nic Junn C Tambal, Nina Alvarez
Meningioma is the most common brain tumor among all histologically reported malignant and non-malignant tumors of the central nervous system. Angiomatous meningioma is one of the subtypes of meningioma that is rarely reported. In this paper, we present a case of a 67-year-old female patient who sought consultation due to seizure, cognitive decline, and parkinsonism. Contrast-enhanced MRI showed a well-defined tumor in the left frontal lobe convexity with extensive perilesional edema. A tumor excision was done and histopathology studies revealed an angiomatous meningioma subtype...
April 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37151155/the-korean-society-for-neuro-oncology-ksno-guideline-for-the-management-of-brain-tumor-patients-during-the-crisis-period-a-consensus-survey-about-specific-clinical-scenarios-version-2023-1
#34
JOURNAL ARTICLE
Min-Sung Kim, Se-Il Go, Chan Woo Wee, Min Ho Lee, Seok-Gu Kang, Kyeong-O Go, Sae Min Kwon, Woohyun Kim, Yun-Sik Dho, Sung-Hye Park, Youngbeom Seo, Sang Woo Song, Stephen Ahn, Hyuk-Jin Oh, Hong In Yoon, Sea-Won Lee, Joo Ho Lee, Kyung Rae Cho, Jung Won Choi, Je Beom Hong, Kihwan Hwang, Chul-Kee Park, Do Hoon Lim
BACKGROUND: During the coronavirus disease 2019 (COVID-19) pandemic, there was a shortage of medical resources and the need for proper treatment guidelines for brain tumor patients became more pressing. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, has undertaken efforts to develop a guideline that is tailored to the domestic situation and that can be used in similar crisis situations in the future. As part II of the guideline, this consensus survey is to suggest management options in specific clinical scenarios during the crisis period...
April 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37151154/the-korean-society-for-neuro-oncology-ksno-guideline-for-the-management-of-brain-tumor-patients-during-the-crisis-period-a-consensus-recommendation-using-the-delphi-method-version-2023-1
#35
JOURNAL ARTICLE
Min-Sung Kim, Se-Il Go, Chan Woo Wee, Min Ho Lee, Seok-Gu Kang, Kyeong-O Go, Sae Min Kwon, Woohyun Kim, Yun-Sik Dho, Sung-Hye Park, Youngbeom Seo, Sang Woo Song, Stephen Ahn, Hyuk-Jin Oh, Hong In Yoon, Sea-Won Lee, Joo Ho Lee, Kyung Rae Cho, Jung Won Choi, Je Beom Hong, Kihwan Hwang, Chul-Kee Park, Do Hoon Lim
BACKGROUND: During the coronavirus disease 2019 (COVID-19) pandemic, the need for appropriate treatment guidelines for patients with brain tumors was indispensable due to the lack and limitations of medical resources. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, has undertaken efforts to develop a guideline that is tailored to the domestic situation and that can be used in similar crisis situations in the future. METHODS: The KSNO Guideline Working Group was composed of 22 multidisciplinary experts on neuro-oncology in Korea...
April 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37151153/octogenarian-brain-tumor-registry-single-institution-surgical-outcomes-and-mortality-study
#36
JOURNAL ARTICLE
Katharine R Phillips, Aristotelis Filippidis, Charles E Mackel, Alejandro Enriquez-Marulanda, Rafael A Vega
BACKGROUND: Surgical intervention for brain tumor patients aged 80 to 89 years is controversial, as the comorbidities and physiology associated with aging are often thought to increase surgical risks. Surgical outcomes, however, are not well characterized for octogenarians. This review therefore assessed the outcomes and mortality risk associated with tumor removal in octogenarians at our academic institution. METHODS: Retrospective review of patients aged 80 to 89 who underwent craniotomy for tumor resection (CTR) at our institution between 2004-2021 and who were diagnosed with meningioma, glioblastoma, or metastatic disease...
April 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37151152/intracranial-metastasis-of-extracranial-chondrosarcoma-systematic-review-with-illustrative-case
#37
JOURNAL ARTICLE
Charles E Mackel, Harry Rosenberg, Hemant Varma, Erik J Uhlmann, Rafael A Vega, Ron L Alterman
BACKGROUND: Cerebral chondrosarcoma metastases are rare and aggressive neoplasms. The rarity of presentation has precluded rigorous analysis of diagnosis, risk factors, treatment, and survival. We analyzed every reported case through exhaustive literature review. We further present the first case with Maffucci syndrome. METHODS: Three databases, PubMed, Embase, and Google Scholar, and crossed references were queried for cerebral chondrosarcoma metastases. Extracted variables included demographics, risk factors, tumor characteristics, interventions, and outcomes...
April 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37151151/distinct-specialized-center-of-excellence-the-story-of-hwasun-neurosurgery-at-chonnam-national-university-hwasun-hospital
#38
REVIEW
Shin Jung, In-Young Kim, Kyung-Sub Moon, Tae-Young Jung, Woo-Youl Jang, Yeong Jin Kim, Tae-Kyu Lee, Sue Jee Park, Sa-Hoe Lim
The paper provides a comprehensive overview of the growth and development of Hwasun Neurosurgery at Chonnam National University Hwasun Hospital over the past 18 years. As the first brain tumor center in Korea when it was established in April 2004, Hwasun Neurosurgery has since become one of the leading institutions in brain tumor education and research in the country. Its impressive clinical and basic research capabilities, dedication to professional education, and numerous academic achievements have all contributed to its reputation as a top-tier institution...
April 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37151150/epigenetic-and-metabolic-changes-in-diffuse-intrinsic-pontine-glioma
#39
REVIEW
Jiyoon Park, Chan Chung
Diffuse midline glioma (DMG), hitherto known as diffuse intrinsic pontine glioma (DIPG), is a rare and aggressive form of brain cancer that primarily affects children. Although the exact cause of DMG/DIPG is not known, a large proportion of DMG/DIPG tumors harbor mutations in the gene encoding the histone H3 protein, specifically the H3K27M mutation. This mutation decreases the level of H3K27me3, a histone modification that plays a vital role in regulating gene expression through epigenetic regulation. The mutation also alters the function of polycomb repressive complex 2 (PRC2), thereby preventing the repression of genes associated with cancer development...
April 2023: Brain Tumor Research and Treatment
https://read.qxmd.com/read/37151149/radiotherapy-for-diffuse-intrinsic-pontine-glioma-insufficient-but-indispensable
#40
REVIEW
Hyun Ju Kim, Chang-Ok Suh
Diffuse intrinsic pontine gliomas (DIPGs) account for 10%-20% of all central nervous system tumors in children and are the leading cause of death in children with brain tumors. Although many clinical trials have been conducted over the past decades, the survival outcome has remained unchanged. Over 90% of children die within 2 years of the diagnosis, and radiotherapy remains the standard treatment to date. To improve the prognosis, hyperfractionated and hypofractionated radiotherapy and/or addition of radiosensitizers have been investigated...
April 2023: Brain Tumor Research and Treatment
journal
journal
48347
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.